Search Results - "Decosta, L."
-
1
CJ-15,696 and its analogs, new furopyridine antibiotics from the fungus Cladobotryum varium: fermentation, isolation, structural elucidation, biotransformation and antibacterial activities
Published in Journal of antibiotics (01-01-2002)“…CJ-15,696 and 7 novel furopyridine antibiotics were isolated from the fungus Cladobotryum varium CL12284. Their structures were determined by X-ray…”
Get more information
Journal Article -
2
53P Incidence of febrile neutropenia (FN), adherence and compliance to granulocyte colony-stimulating factor (G-CSF) on-body injector (OBI) versus other FN prophylaxis in patients receiving myelosuppressive chemotherapy: Subgroup analysis in breast cancer patients
Published in Annals of oncology (01-05-2021)Get full text
Journal Article -
3
-
4
-
5
Modeling Covariate-Adjusted Survival for Economic Evaluations in Oncology
Published in Value in health (01-10-2017)“…OBJECTIVES: Survival data from randomized controlled trials (RCT) is routinely extrapolated for economic evaluations in oncology. Imbalances in prognostic and/…”
Get full text
Journal Article -
6
MO3 - Modeling Covariate-Adjusted Survival for Economic Evaluations in Oncology
Published in Value in health (01-10-2017)Get full text
Journal Article -
7
-
8
-
9
PCN121 - Retrospective Chart Review Study to Evaluate the Cost of Care of Patients with Symptomatic Multiple Myeloma in France
Published in Value in health (01-05-2016)Get full text
Journal Article -
10
PCN124 - Chart Review Study to Evaluate Health Care Resource Utilization of Patients with Symptomatic Multiple Myeloma in the United Kingdom
Published in Value in health (01-05-2016)Get full text
Journal Article -
11
Chart Review Study to Evaluate Health Care Resource Utilization of Patients with Symptomatic Multiple Myeloma in the United Kingdom
Published in Value in health (01-05-2016)Get full text
Journal Article -
12
Retrospective Chart Review Study to Evaluate the Cost of Care of Patients with Symptomatic Multiple Myeloma in France
Published in Value in health (01-05-2016)Get full text
Journal Article -
13
Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies
Published in Clinical lymphoma, myeloma and leukemia (01-06-2018)“…The Registry of Monoclonal Gammopathies (RMG) collects long-term data for patients with hematologic malignancies and is one of the largest registries of its…”
Get full text
Journal Article -
14
-
15
1496PATTITUDES OF PHYSICIANS TOWARD RISK ASSESSMENT AND USE OF GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) AS PRIMARY PROPHYLAXIS (PP) IN PATIENTS (PTS) RECEIVING CHEMOTHERAPY WITH AN INTERMEDIATE RISK OF FEBRILE NEUTROPENIA (FN)
Published in Annals of oncology (01-09-2014)“…Abstract Aim: For chemotherapy regimens with intermediate FN risk (10–20%), physicians should assess patient risk factors to determine whether overall risk is…”
Get full text
Journal Article -
16
Attitudes of Physicians Toward Risk Assessment and Use of Granulocyte-Colony Stimulating Factor (G-Csf) As Primary Prophylaxis (Pp) in Patients (Pts) Receiving Chemotherapy with an Intermediate Risk of Febrile Neutropenia (Fn)
Published in Annals of oncology (01-09-2014)Get full text
Journal Article -
17
Retrospective Chart Review Study to Evaluate Health Care Resource Utilization in Patients with Symptomatic Multiple Myeloma in Italy
Published in Value in health (01-05-2016)Get full text
Journal Article -
18
PCN123 - Retrospective Chart Review Study to Evaluate Health Care Resource Utilization in Patients with Symptomatic Multiple Myeloma in Italy
Published in Value in health (01-05-2016)Get full text
Journal Article -
19
Long-Term Disease Outcomes in Symptomatic Multiple Myeloma Patients: A Retrospective Analysis of the Pharos Registry
Published in Value in health (01-05-2016)Get full text
Journal Article -
20
PCN204 - Long-Term Disease Outcomes in Symptomatic Multiple Myeloma Patients: A Retrospective Analysis of the Pharos Registry
Published in Value in health (01-05-2016)Get full text
Journal Article